Skip to content
SFN info

Lupus and Small Fiber Neuropathy (SFN)

Introduction to Lupus

Description:

Lupus, officially known as systemic lupus erythematosus (SLE), is a chronic autoimmune disease. In this condition, the body’s immune system mistakenly attacks its own tissues and organs, leading to inflammation and damage. It can affect various parts of the body including the skin, joints, kidneys, heart, lungs, blood cells, and brain. The exact cause of lupus is unknown, but it’s believed to be a combination of genetic, environmental, and hormonal factors.

Prevalence:

According to the Lupus Foundation of America, approximately 1.5 million Americans and at least five million people worldwide have a form of lupus. The disease can occur at any age, but it most often appears between the ages of 15 and 44.

Risk Factors:

Several risk factors are associated with the development of lupus:

  • Gender: Lupus is more common in women than men.
  • Age: While lupus can occur at any age, it is most commonly diagnosed in people between the ages of 15 and 44.
  • Race/Ethnicity: Lupus is more prevalent in people of non-European descent, including African-Americans, Hispanics/Latinos, Asians, and Native Americans.
  • Family History: Individuals with a family history of lupus or other autoimmune diseases are at a higher risk.

Prognosis:

The prognosis of lupus varies widely depending on the organs involved and the severity of the disease. Some people may have mild symptoms and a relatively normal lifespan, while others may experience severe, life-threatening complications. Common complications of lupus include kidney damage, heart problems, lung damage, infections, bone tissue death, and an increased risk of cancer. With appropriate treatment and management, most people with lupus can lead a full life.

Prevention:

There is no known way to prevent lupus since its exact cause is unknown. However, managing risk factors and maintaining a healthy lifestyle can help reduce the severity of symptoms and complications. This includes regular exercise, a balanced diet, adequate rest, stress management, and avoiding excessive sun exposure.

Epidemiology:

The prevalence of lupus varies by region, age, and gender. In the United States, lupus is more common in African-Americans and Hispanics/Latinos than in Caucasians. It is also 2-3 times more prevalent among women of color compared to Caucasian women. Lupus can occur at any age but is most commonly diagnosed in people between the ages of 15 and 44. Women are significantly more likely to develop lupus than men, with about 9 out of 10 adult lupus patients being female.

Lupus connection to Small Fiber Neuropathy (SFN)

Association:

Lupus, also known as systemic lupus erythematosus (SLE), is an autoimmune disease where the body’s immune system mistakenly attacks healthy tissue in many parts of the body. This can lead to inflammation and damage to various body tissues, including nerves.

Small Fiber Neuropathy (SFN) is a condition characterized by severe pain attacks that typically begin in the feet or hands, as well as loss of temperature sensation. It is caused by damage to the small fibers of the peripheral nervous system.

The link between Lupus and SFN is not fully understood, but several mechanisms have been proposed:

  • Inflammation: Lupus can cause chronic inflammation, which may damage the small fibers of the peripheral nervous system, leading to SFN.
  • Autoimmune attack: In Lupus, the immune system can mistakenly attack the small fibers, causing SFN.
  • Vasculitis: Lupus can cause vasculitis, an inflammation of the blood vessels, which can lead to nerve damage and SFN.

Research Updates:

Recent research has continued to explore the link between Lupus and SFN. Some key findings include:

  • A 2019 study published in the “Journal of Neurology” found that Lupus patients with SFN had higher disease activity and more severe symptoms than those without SFN.
  • A 2020 study published in the “Journal of Rheumatology” found that SFN was associated with a higher risk of cardiovascular disease in Lupus patients.
  • A 2021 study published in the “Journal of Clinical Rheumatology” found that SFN was more common in Lupus patients with a history of Raynaud’s phenomenon, a condition that affects blood flow to the fingers and toes.

These studies suggest that SFN may be an important aspect of Lupus that needs further research and attention.

Symptoms of Lupus

List of Symptoms:

Lupus is a systemic autoimmune disease that occurs when the body’s immune system attacks its own tissues and organs. The symptoms can vary widely from person to person, and they may come and go. Here are some common symptoms associated with Lupus:

  • Fatigue and fever: These are often the first signs of Lupus.
  • Joint pain, stiffness, and swelling: Lupus can cause pain, stiffness, and swelling in your joints, particularly in the morning.
  • Butterfly-shaped rash on the face: This rash, which covers the cheeks and bridge of the nose, is a classic sign of Lupus. However, not everyone with Lupus develops this rash.
  • Skin lesions that appear or worsen with sun exposure (photosensitivity)
  • Shortness of breath: Lupus can cause inflammation in the lungs or the lining around the lungs, leading to difficulty breathing.
  • Chest pain: If Lupus affects the heart or the lining around the heart, it can cause chest pain.
  • Dry eyes
  • Headaches, confusion, and memory loss

In relation to Small Fiber Neuropathy (SFN), Lupus patients may experience peripheral neuropathy, which can cause:

  • Numbness, tingling, or burning in the hands and feet
  • Extreme sensitivity to touch
  • Pain during activities that shouldn’t cause pain, such as pain in your feet when they’re under a blanket

Severity:

The severity of Lupus symptoms can range from mild to severe. Some people may only experience a few mild symptoms, such as fatigue and joint pain. Others may have more severe symptoms, such as kidney inflammation leading to kidney failure, a complication that can be life-threatening. The severity of symptoms can also fluctuate over time in the same person, with periods of worsening symptoms (flares) and periods of mild or no symptoms (remission).

Onset:

Lupus symptoms can appear at any stage of life, but they most commonly start in people between the ages of 15 and 45. The symptoms typically appear gradually over time, although they can also appear suddenly. Early symptoms often include fatigue, fever, and joint pain. As the disease progresses, other symptoms such as skin rashes, kidney problems, and neurological symptoms (including those associated with SFN) may develop. It’s important to be aware that Lupus can be difficult to diagnose because its symptoms are so varied and can mimic those of other diseases.

Diagnosis of Lupus

Methods:

Diagnosing lupus can be challenging due to its varied symptoms that can mimic other conditions. However, the following methods are commonly used:

  • Medical History: A comprehensive review of the patient’s medical history is crucial. This includes any symptoms, their duration, and any family history of lupus or other autoimmune diseases.

  • Physical Examination: The physician will conduct a thorough physical examination, looking for typical signs of lupus such as a rash (particularly a butterfly-shaped rash across the cheeks and nose), arthritis, and oral ulcers.

  • Laboratory Tests: These are used to detect changes in the body that may indicate lupus. They include:

    • Complete blood count (CBC): This test measures the number of red blood cells, white blood cells, and platelets as well as the amount of hemoglobin, a protein in red blood cells.
    • Erythrocyte sedimentation rate (ESR): This test can reveal inflammatory activity in the body.
    • Kidney and liver assessment: Blood tests can assess how well these organs are functioning.
    • Urinalysis: This test can indicate kidney inflammation or kidney damage.
    • Antinuclear antibody (ANA) test: This test detects antibodies that can indicate an autoimmune disease like lupus. A positive test doesn’t confirm lupus, but it can be a starting point for further diagnostic tests.
    • Immunologic tests: These tests look for specific autoantibodies associated with lupus, such as anti-dsDNA, anti-Sm, anti-RNP, anti-Ro/SSA, and anti-La/SSB antibodies.

  • Imaging Tests: Chest x-rays can reveal abnormal shadows that suggest fluid or inflammation in the lungs, which can occur in lupus. An echocardiogram can show problems with the valves or other parts of the heart.

Differential Diagnosis:

Several conditions can mimic lupus, especially in the context of small fiber neuropathy (SFN), including:

  • Fibromyalgia: This condition causes muscle pain and fatigue and can mimic the joint pain and fatigue seen in lupus.

  • Rheumatoid Arthritis (RA): RA is another autoimmune disease that can cause joint pain and fatigue similar to lupus.

  • Sjögren’s Syndrome: This condition can cause dry eyes and mouth, fatigue, and joint pain, similar to lupus.

  • Vasculitis: This inflammation of the blood vessels can cause symptoms similar to lupus.

  • Other Connective Tissue Diseases: Conditions such as scleroderma and dermatomyositis can have overlapping symptoms with lupus.

Limitations:

There are several challenges in diagnosing lupus, including:

  • Overlapping Symptoms: Lupus symptoms can mimic many other conditions, making it difficult to diagnose.

  • Variability of Symptoms: Symptoms can vary greatly from one person to another and can also change or evolve over time.

  • Lack of a Single Definitive Test: There is no single test that can definitively diagnose lupus. The diagnosis is usually based on a combination of symptoms and laboratory findings.

  • Flares and Remissions: Lupus is characterized by periods of illness (flares) and periods of wellness (remissions), which can complicate diagnosis.

  • SFN and Lupus: Diagnosing lupus in the context of SFN can be particularly challenging due to the overlap in symptoms and the fact that SFN can be a manifestation of lupus itself.

Treatments for Lupus

Options:

Lupus, also known as systemic lupus erythematosus (SLE), is a chronic autoimmune disease that can affect any part of the body. When Lupus is linked to Small Fiber Neuropathy (SFN), the treatment plan often involves managing the symptoms of both conditions. Here are some treatment options:

  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): These are used to treat pain and inflammation associated with Lupus. Over-the-counter NSAIDs include ibuprofen and naproxen. Stronger NSAIDs are available by prescription.

  • Corticosteroids: These drugs, such as prednisone, can be effective in reducing inflammation and suppressing the immune system. They are often used in more severe cases of Lupus.

  • Antimalarial Drugs: Medications originally used to prevent or treat malaria, such as hydroxychloroquine, can help manage Lupus symptoms. They are often used in combination with other drugs.

  • Immunosuppressants: These drugs suppress the immune system to reduce its attack on the body’s own tissues. Examples include azathioprine, mycophenolate, leflunomide, and methotrexate.

  • Biologics: These are a newer type of drug that target specific parts of the immune system. Belimumab is a biologic approved for treating Lupus.

  • Nerve pain medications: For Lupus patients with SFN, medications specifically targeting nerve pain, such as gabapentin or pregabalin, may be used.

Effectiveness:

The effectiveness of these treatments can vary greatly from person to person, as Lupus symptoms and severity differ among individuals. In general, these treatments aim to reduce inflammation, manage symptoms, and prevent flares. For Lupus patients with SFN, nerve pain medications can be effective in managing neuropathic pain.

Side Effects:

All medications have potential side effects. Here are some associated with the treatments for Lupus:

  • NSAIDs: These can cause stomach upset, cardiovascular problems, kidney damage, and liver problems.

  • Corticosteroids: Long-term use can lead to weight gain, increased risk of infections, osteoporosis, high blood pressure, and diabetes.

  • Antimalarial Drugs: These can cause stomach upset, and in rare cases, damage to the retina of the eye.

  • Immunosuppressants: These can increase the risk of infections, liver damage, and infertility.

  • Biologics: These can cause allergic reactions and increase the risk of infections.

  • Nerve pain medications: These can cause dizziness, weight gain, swelling, and dry mouth.

Recent Advancements:

Research into new treatments for Lupus is ongoing. Recent advancements include:

  • Belimumab: This is the first new drug approved for Lupus in over 50 years. It is a biologic that targets a specific protein in the immune system.

  • New biologics and small molecules: Other biologics and small molecules are being studied in clinical trials, including anifrolumab and voclosporin.

  • Stem cell transplantation: This is an experimental treatment that aims to “reset” the immune system. It is currently being studied in clinical trials.

  • Nanomedicine: This is a new field that uses nanoparticles to deliver drugs directly to affected tissues, potentially increasing effectiveness and reducing side effects. This approach is still in the early stages of research.